Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel-Cohort Phase 1 Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute Graft Versus Host Disease

NCT02614612 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT02614612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02614612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel-Cohort Phase 1 Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute Graft Versus Host Disease
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2015
Completion date
August 31, 2018
Enrollment
31 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease (gvhd)